
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1016 | 987 | 1273 | 1572 | 2527 | 3812 |
Fund Return | 1.57% | -1.25% | 27.28% | 16.27% | 20.37% | 14.32% |
Place in category | 549 | 916 | 74 | 273 | 28 | 64 |
% in Category | 51 | 78 | 6 | 28 | 4 | 11 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AGF Global Select Series F | 5.49B | 4.81 | 15.83 | 16.40 | ||
AGF Global Dividend Fund | 2.49B | 5.53 | 12.40 | 7.58 | ||
AGF Global Dividend Fund Series F | 2.49B | 5.74 | 13.72 | 8.83 | ||
AGF Global Equity Series F | 815.74M | 5.84 | 12.46 | 8.49 | ||
AGF Global Equity | 815.74M | 5.61 | 10.89 | 6.96 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
RBC Priv US Lg Cap Cr Eq Pool Sr F | 5.58B | 2.45 | 17.24 | 13.30 | ||
DFA US Core Equity Class F | 5.73B | 2.17 | 15.46 | 12.34 | ||
TD U.S. Blue Chip Equity Fund D USD | 5.26B | 1.25 | 11.64 | - | ||
TD U.S. Blue Chip Equity Fund I USD | 5.26B | 1.06 | 10.55 | 11.97 | ||
CIBC Nasdaq Index | 3.62B | -0.07 | 18.10 | 17.95 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Amazon.com | US0231351067 | 7.47 | 195.53 | +1.41% | |
NVIDIA | US67066G1040 | 6.55 | 117.52 | +1.81% | |
Boston Scientific | US1011371077 | 4.75 | 100.73 | +1.52% | |
Alphabet A | US02079K3059 | 4.70 | 163.96 | +2.05% | |
Intuitive Surgical | US46120E6023 | 4.43 | 491.98 | +1.66% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review